CD8+ T cell depletion amplifies hepatitis C virus replication in peripheral blood mononuclear cells

Journal of Infectious Diseases

Volumn 192, Issue 6, 2005, Pages 1093-1101

  Li, Yuan ^a   Wang, Xu ^a   Douglas, Steven D ^a   Metzger, David S ^b   Woody, George ^b   Zhang, Ting ^a   Song, Li ^a   Ho, Wen Zhe ^a,b  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; VIRUS RNA;

ADULT; ANTIVIRAL ACTIVITY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENE EXPRESSION; HEPATITIS C; HEPATITIS C VIRUS; HOST RESISTANCE; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; IMMUNOPATHOGENESIS; INNATE IMMUNITY; LIVER CELL; LYMPHOCYTE CULTURE; LYMPHOCYTE DEPLETION; NONCYTOTOXIC ANTIVIRAL ACTIVITY; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; REPLICON; T LYMPHOCYTE SUBPOPULATION; VIRUS REPLICATION;

ANTIVIRAL AGENTS; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; HEPACIVIRUS; HUMANS; INTERFERON TYPE II; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE DEPLETION; RNA, VIRAL; VIRUS REPLICATION;

EID: 24644458793     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/432957     Document Type: Article

References (59)

1. + T cells during primary activation. Int Immunol 2002; 14:605-13.
2. Kagi D, Ledermann B, Burki K, et al. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature 1994; 369:31-7.
3. Madden LJ, Zandonatti MA, Flynn CT, et al. CD8+ cell depletion amplifies the acute retroviral syndrome. J Neurovirol 2004; 10:58-66.
4. Walker CM, Moody DJ, Stiles DP, Levy JA. CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication. Science 1986; 234:1563-6.
5. Walker CM, Levy JA. A diffusible lymphokine produced by CD8+ T lymphocytes suppresses HIV replication. Immunology 1989; 66:628-30.
6. Levy JA. Pathogenesis of human immunodeficiency virus infection. Microbiol Rev 1993; 57:183-289.
7. Walker CM, Moody DJ, Stiles DP, Levy JA. CD8+ T lymphocyte control of HIV replication in cullured CD4+ cells varies among infected individuals. Cell Immunol 1989; 119:470-5.
8. Schmitz JE, Kuroda MJ, Santra S, et al. Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. Science 1999; 283:857-60.
9. Chisari FV. Cytotoxic T cells and viral hepatitis. J Clin Invest 1997; 99:1472-7.
10. Sester M, Sester U, Gartner BC, Girndt M, Meyerhans A, Kohler H. Dominance of virus-specific CD8 T cells in human primary cytomegalovirus infection. J Am Soc Nephrol 2002; 13:2577-84.
11. + T lymphocytes and increased EBV load in HIV-1 infected individuals progressing to AIDS-related non-Hodgkin lymphoma. Blood 2001; 98:146-55.
12. Rehermann B, Chang KM, McHutchison JG, Kokka R, Houghton M, Chisari FV. Quantitative analysis of the peripheral blood cytotoxic T lymphocyte response in patients with chronic hepatitis C virus infection. J Clin Invest 1996; 98:1432-40.
13. + T-cell responsiveness in hepatitis C virus infection. Hepatology 2001; 33:267-76.
14. He XS, Greenberg HB. CD8+ T-cell response against hepatitis C virus. Viral Immunol 2002; 15:121-31.
15. Guidotti LG, Chisari FV. Noncytolytic conlrol of viral infections by the innate and adaptive immune response. Annu Rev Immunol 2001; 19:65-91.
16. Orange JS, Wang B, Terhorst C, Biron CA. Requirement for natural killer cell-produced interferon gamma in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration. J Exp Med 1995; 182:1045-56.
17. Frese M, Schwarzle V, Barth K, et al. Interferon-gamma inhibits replication of subgenomic and genomic hepatitis C virus RNAs. Hepatology 2002; 35:694-703.
18. Appay V, Dunbar PR, Callan M, et al. Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections. Nat Med 2002; 8:379-85.
19. Gruener NH, Lechner F, Jung MC, et al. Sustained dysfunction of antiviral CD8+ T lymphocytes after infection with hepatitis C virus. J Virol 2001; 75:5550-8.
20. Fong TL, Shindo M, Feinstone SM, Hoofnagle JH, Di Bisceglie AM. Detection of replicative intermediates of hepatitis C viral RNA in liver and serum of patients with chronic hepatitis C. J Clin Invest 1991; 88: 1058-60.
21. Wang JT, Sheu JC, Lin JT, Wang TH, Chen DS. Detection of replicative form of hepatitis C virus RNA in peripheral blood mononuclear cells. J Infect Dis 1992; 166:1167-9.
22. Muller HM, Pfaff E, Goeser T, Kallinowski B, Solbach C, Theilmann L. Peripheral blood leukocytes serve as a possible extrahepatic site for hepatitis C virus replication. J Gen Virol 1993; 74:669-76.
23. Willems M, Peerlinck K, Moshage H, et al. Hepatitis C virus-RNAs in plasma and in peripheral blood mononuclear cells of hemophiliacs with chronic hepatitis C: evidence for viral replication in peripheral blood mononuclear cells. J Med Virol 1994; 42:272-8.
24. Lerat H, Berby F, Trabaud MA, et al. Specific detection of hepatitis C virus minus strand RNA in hematopoietic cells. J Clin Invest 1996; 97: 845-51.
25. Laskus T, Radkowski M, Wang LF, Vargas H, Rakela J. The presence of active hepatitis C virus replication in lymphoid tissue in patients coinfected with human immunodeficiency virus type 1. J Infect Dis 1998; 178:1189-92.
26. Laskus T, Radkowski M, Piasek A, et al. Hepatitis C virus in lymphoid cells of patients coinfected with human immunodeficiency virus type 1: evidence of active replication in monocytes/macrophages and lymphocytes. J Infect Dis 2000; 181:442-8.
27. Crovatto M, Pozzato G, Zorat F, et al. Peripheral blood neutrophils from hepatitis C virus-infected patients are replication sites of the virus. Haematologica 2000; 85:356-61.
28. Li Y, Wang X, Tian S, Guo CJ, Douglas SD, Ho WZ. Methadone enhances human immunodeficiency virus infection of human immune cells. J Infect Dis 2002; 185:118-22.
29. Blight KJ, Kolykhalov AA, Rice CM. Efficient initiation of HCV RNA replication in cell culture. Science 2000; 290:1972-4.
30. Yang JH, Lai JP, Douglas SD, Metzger D, Zhu XH, Ho WZ. Real-time RT-PCR for quantitation of hepatitis C virus RNA. J Virol Methods 2002; 102:119-28.
31. Guo JT, Bichko W, Seeger C. Effect of alpha interferon on the hepatitis C virus replicon. J Virol 2001; 75:8516-23.
32. Li Y, Zhang T, Douglas SD, et al. Morphine enhances hepatitis C virus (HCV) replicon expression. Am J Pathol 2003; 163:1167-75.
33. Li Y, Zhang T, Ho C, Orange JS, Douglas SD, Ho WZ. Natural killer cells inhibit hepatitis C virus expression. J Leukoc Biol 2004; 76:1171-9.
34. Laskus T, Radkowski M, Jablonska J, et al. Human immunodeficiency virus facilitates infection/replication of hepatitis C virus in native human macrophages. Blood 2004; 103:3854-9.
35. Rosenberg S. Recent advances in the molecular biology of hepatitis C virus. J Mol Biol 2001; 313:451-64.
36. Lohmann V, Korner F, Koch J, Herian U, Theilmann L, Bartenschlager R. Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science 1999; 285:110-3.
37. Liu C, Zhu H, Tu Z, Xu YL, Nelson DR. CD8+ T-cell interaction with HCV replicon cells: evidence for both cytokine- and cell-mediated antiviral activity. Hepatology 2003; 37:1335-42.
38. Lamelin JP, Zoulim F, Trepo C. Lymphotropism of hepatitis B and C viruses: an update and a newcomer. Int J Clin Lab Res 1995; 25:1-6.
39. Santini GF, Giannini F, Crovatto M, et al. HCV and lymphoproliferative diseases. Clin Exp Rheumatol 1995; 13(Suppl 13):S51-7.
40. Bouffard P, Hayashi PH, Acevedo R, Levy N, Zeldis JB. Hepatitis C virus is detected in a monocyte/macrophage subpopulation of peripheral blood mononuclear cells of infected patients. J Infect Dis 1992; 166:1276-80.
41. Nelson DR, Marousis CG, Davis GL, et al. The role of hepatitis C virus-specific cytotoxic T lymphocytes in chronic hepatitis C. J Immunol 1997; 158:1473-81.
42. Rice CM, Walker CM. Hepatitis C virus-specific T lymphocyte responses. Curr Opin Immunol 1995; 7:532-8.
43. Koziel MJ. The role of immune responses in the pathogenesis of hepatitis C virus infection. J Viral Hepat 1997; 4:31-41.
44. Erickson AL, Houghton M, Choo QL, et al. Hepatitis C virus-specific CTL responses in the liver of chimpanzees with acute and chronic hepatitis C. J Immunol 1993; 151:4189-99.
45. Cooper S, Erickson AL, Adams EJ, et al. Analysis of a successful immune response against hepatitis C virus. Immunity 1999; 10:439-49.
46. Ferbas J. Perspectives on the role of CD8+ cell suppressor factors and cytotoxic T lymphocytes during HIV infection. AIDS Res Hum Retroviruses 1998; 14(Suppl 2):S153-60.
47. Levy JA, Mackewicz CE, Barker E. Controlling HIV pathogenesis: the role of the noncytotoxic anti-HIV response of CD8+ T cells. Immunol Today 1996; 17:217-24.
48. Walker BD, Chakrabarti S, Moss B, et al. HIV-specific cytotoxic T lymphocytes in seropositive individuals. Nature 1987; 328:345-8.
49. Tsubota H, Lord CI, Watkins DI, Morimoto C, Letvin NL. A cytotoxic T lymphocyte inhibits acquired immunodeficiency syndrome virus replication in peripheral blood lymphocytes. J Exp Med 1989; 169:1421-34.
50. Carmichael A, Jin X, Sissons P, Borysiewicz L. Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein-Barr virus in late disease. J Exp Med 1993; 177:249-56.
51. Mackewicz CE, Ortega HW, Levy JA. CD8+ cell anti-HIV activity correlates with the clinical state of the infected individual. J Clin Invest 1991; 87:1462-6.
52. Walker BD, Plata F. Cytotoxic T lymphocytes against HIV. AIDS 1990; 4: 177-84.
53. Castro BA, Walker CM, Eichberg JW, Levy JA. Suppression of human immunodeficiency virus replication by CD8+ cells from infected and uninfected chimpanzees. Cell Immunol 1991; 132:246-55.
54. Grene E, Pinto LA, Cohen SS, et al. Generation of alloantigen-stimulated anti-human immunodeficiency virus activity is associated with HLA-A*02 expression. J Infect Dis 2001; 183:409-16.
55. +-cell antiviral factor activity is not restricted to human immunodeficiency virus (HIV)-specific T cells and can block HIV replication after initiation of reverse transcription. J Virol 2000; 74:4456-64.
56. Pinto LA, Blazevic V, Patterson BK, Mac Trubey C, Dolan MJ, Shearer GM. Inhibition of human immunodeficiency virus type 1 replication prior to reverse transcription by influenza virus stimulation. J Virol 2000; 74:4505-11.
57. Lechner F, Wong DK, Dunbar PR, et al. Analysis of successful immune responses in persons infected with hepatitis C virus. J Exp Med 2000; 191: 1499-512.
58. Thimme R, Oldach D, Chang KM, Steiger C, Ray SC, Chisari FV. Determinants of viral clearance and persistence during acute hepatitis C virus infection. J Exp Med 2001; 194:1395-406.
59. Wedemeyer H, He XS, Nascimbeni M, et al. Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection. J Immunol 2002; 169:3447-58.